Synthesis and Application of a Novel Multifunctional Nanoprodrug for Synergistic Chemotherapy and Phototherapy with Hydrogen Sulfide Gas
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c02426 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Silan Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, 605 Fenglin Rd.,…. Hauptthemen laut MEDLINE: Hydrogen Sulfide, Prodrugs, Antineoplastic Agents. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province, Jiangxi Science and Technology Normal University.
Themen: Onkologische Pflege
Abstract (Originalsprache)
With the dilemma of limited efficacy of individual therapies, it is crucial to develop innovative combination therapy systems to target the complex pathogenesis of cancer. In this study, we designed a nanoprodrug ISL@MIL-101-ADT to facilitate synergistic delivery of hydrogen sulfide (H2S) and prodrug ISL for specific eradication of tumor cells with minimal toxicity and maximal efficacy. The nanoprodrug passively targeted tumors through enhanced permeation and retention effects, followed by disintegration and release of IR780, lonidamine (LND), and H2S. IR780 localizes LND to mitochondria to enhance therapeutic effects and turn on the phototherapy and chemotherapy when exposed to a laser; H2S inhibits procancer signaling pathways and mitochondrial function. In vivo experiments have demonstrated that ISL@MIL-101-ADT exhibits excellent pharmacokinetic properties and significant tumor inhibitory effects. Additionally, this nanoprodrug possesses outstanding photothermal and fluorescence imaging capabilities. Therefore, we strongly believe that the nanoprodrug present herein holds great potential for application in cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, 605 Fenglin Rd., Nanchang, Jiangxi 330013, China.
- Jiang Xi Institute for Drug Control, Jiangxi Provincial Drug Administration, 1566 Beijing East Road, Nanchang, Jiangxi 330029, China.
ORCID-Profile: Qingshan Pan, Dan Qiao, Wufu Zhu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
- Jiangxi Science and Technology Normal University
Zitieren
APA
Yang, S., Liu, Y., Wu, T., Zhang, X., Xu, S., Pan, Q., Zhu, L., Zheng, P., Qiao, D., & Zhu, W. (2025). Synthesis and Application of a Novel Multifunctional Nanoprodrug for Synergistic Chemotherapy and Phototherapy with Hydrogen Sulfide Gas. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02426
Vancouver
Yang S, Liu Y, Wu T, Zhang X, Xu S, Pan Q, et al. Synthesis and Application of a Novel Multifunctional Nanoprodrug for Synergistic Chemotherapy and Phototherapy with Hydrogen Sulfide Gas. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c02426
BibTeX
@article{Yang2025,
author = {Yang, Silan and Liu, Yijun and Wu, Tianyu and Zhang, Xuan and Xu, Shan and Pan, Qingshan and Zhu, Lianghui and Zheng, Pengwu and Qiao, Dan and Zhu, Wufu},
title = {Synthesis and Application of a Novel Multifunctional Nanoprodrug for Synergistic Chemotherapy and Phototherapy with Hydrogen Sulfide Gas},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c02426}
}
EUVIMED